Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways - Test2 - elhamkhani - TriplyDB

Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways

Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways

http://www.wikidata.org/entity/Q28386376

about

Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation Targeted Lung Delivery of Nasally Administered Aerosols High-efficiency generation and delivery of aerosols through nasal cannula during noninvasive ventilation Targeting aerosol deposition to and within the lung airways using excipient enhanced growth Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance Variability in Nose-to-Lung Aerosol Delivery Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery Development of high efficiency ventilation bag actuated dry powder inhalers.In silico models of aerosol delivery to the respiratory tract - development and applications.Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: comparison of CFD predictions with experimental results Airway responsiveness depends on the diffusion rate of methacholine across the airway wall Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.Production of Inhalable Submicrometer Aerosols from Conventional Mesh Nebulizers for Improved Respiratory Drug Delivery Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways.Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.Multiscale image-based modeling and simulation of gas flow and particle transport in the human lungs In situ casting and imaging of the rat airway tree for accurate 3D reconstruction.Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.Bioequivalence of inhaled drugs: fundamentals, challenges and perspectives.Early airway structural changes in cystic fibrosis pigs as a determinant of particle distribution and deposition.In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy.Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.Issues determining direct airways hyperresponsiveness in mice.Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.Airflow, transport and regional deposition of aerosol particles during chronic bronchitis of human central airways.Hygroscopic aerosol deposition in the human upper respiratory tract under various thermo-humidity conditions.Dynamic growth and deposition of hygroscopic aerosols in the nasal airway of a 5-year-old child.Development of a Stochastic Individual Path (SIP) Model for Predicting the Deposition of Pharmaceutical Aerosols: Effects of Turbulence, Polydisperse Aerosol Size, and Evaluation of Multiple Lung Lobes

P2860

Q28387314-4CB7E8D8-D773-422B-931C-95DD747BE4C9 Q28387568-5D9EAD3E-AB45-49B0-8886-7D9378396C78 Q28390968-DC32469B-4C03-4DE7-BEC8-CD9272E6E06A Q28390979-1C26F452-D851-475D-B869-C7C815EA11B9 Q28394991-AD9A524F-7264-4B6B-9364-CF0553DA3392 Q28395392-2F38644F-A2E0-4D98-BE9F-E44662E2DC19 Q30945192-F337D1A3-E860-47B8-AE10-F291B984D211 Q33626905-81C8321F-C0FA-4036-89B2-9AA6E98EAF3C Q33732483-6770521B-A3AA-428D-ABDC-A88A3253BE8A Q35673202-8B521670-D504-4C45-BA02-79B466412321 Q35784530-124FB43F-7F0A-49BB-AFB1-49C497E0911B Q36001953-0660FAD3-1E7A-4020-9B77-C938A1986B7A Q36024362-2B10E4A8-115B-4F4C-98C7-B783857B3346 Q36029582-488AFDE5-E202-4EC4-A14D-6C6632EA986D Q36165365-799C6E67-20A0-4413-B82F-BFB01D2B93DA Q36417205-8F37BBCF-6665-4739-BFB1-41EE14594EE5 Q36559720-4C838B5B-A525-4CD0-AA8F-26AD98F9392C Q37148830-60A43817-7382-4B5E-B872-5E89EB28E42D Q37592544-072DD51D-E09E-4BEC-948D-F41465982E6E Q37953309-7FF30438-647F-472D-AD96-A3BBB2809015 Q38084738-40E4CA9D-5CF3-4588-9CF7-A351B280EB75 Q38274644-ECC1CC0F-E609-4F30-ABF2-06D1656F9B02 Q38731069-8EA9617F-644C-4E3C-9D97-569299702EDE Q39658347-F8BBE4D7-4F82-4536-B207-5D3852596449 Q39848034-1EB9316D-ADEF-42AC-8479-031609CB83AB Q42253470-06CEF15F-0DD8-4A92-8897-BA85729281F3 Q45050545-12AC318E-2E89-48CD-A676-49E9264E1E45 Q48643497-D01927C6-84C9-4460-AC0F-233557BB03BB Q48712133-E20C12C0-6026-4EF2-83E1-2F1D2D3352EA Q48742145-FF9696E5-BE6C-4EAE-BF50-437655099FB4 Q58303971-B72A4ED4-1611-4B4C-921D-1AAAA2E23456

P2860

Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways

http://www.wikidata.org/entity/Q28386376

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Characterization of respirator ...... ntire tracheobronchial airways

@ast

Characterization of respirator ...... ntire tracheobronchial airways

@en

Characterization of respirator ...... ntire tracheobronchial airways

@nl

type

label

Characterization of respirator ...... ntire tracheobronchial airways

@ast

Characterization of respirator ...... ntire tracheobronchial airways

@en

Characterization of respirator ...... ntire tracheobronchial airways

@nl

prefLabel

Characterization of respirator ...... ntire tracheobronchial airways

@ast

Characterization of respirator ...... ntire tracheobronchial airways

@en

Characterization of respirator ...... ntire tracheobronchial airways

@nl

P1433

Q28386376-E5516ED5-22B0-435F-B850-5D07B66A91C7

P1476

Q28386376-88DDB8DE-E338-4D90-86C0-923C6163384B

P2093

Q28386376-07071679-D631-4CA6-9B47-0DF2582304ED

Q28386376-2CC5CDE7-F069-4C3B-98FA-DC5FECA0A07F

Q28386376-AA42B8B3-4064-4846-8016-339F714C394B

P2860

Q28386376-011AD43B-225F-4DF0-A8F9-853CB7192D0E

Q28386376-09549054-FA08-4D19-87B3-0A934665C7BC

Q28386376-1B7F4AF0-2F2B-4C79-BBF9-7B3EA0599EEC

Q28386376-1CD7CF7C-BB29-4869-B38A-CBC794467888

Q28386376-27C2A7F7-7815-4D59-934E-EA0B44D6AFB8

Q28386376-2AA91209-AEC4-46D1-A2B5-ED67CA37296A

Q28386376-3082D075-1FC4-411C-A5FE-B90EAB271110

Q28386376-414693D1-1760-42CD-A83A-B13F47C718EF

Q28386376-55B747C8-B164-446C-85A4-B16CE97CF173

Q28386376-5BE95D8F-E935-4ED8-9349-26086980AAD0

P2888

Q28386376-78F35CAA-E7A8-47CD-B6CE-C75804B715DE

P304

Q28386376-3A42A54E-A01B-4CBE-AFBB-94502AD2110B

P31

Q28386376-EB65A6C3-6FF2-4857-918B-66E776DC0C68

P356

Q28386376-7FD34798-C5C1-4E66-9626-B795F9A871FB

P407

Q28386376-318355A3-CFB0-427E-B749-82D4DD33C766

P433

Q28386376-4B60B5D7-F6E9-4486-805C-7AC6E5464DCD

P478

Q28386376-458C3378-68E2-4229-835B-5C990826B0DD

P50

Q28386376-1FBC0882-02B4-4124-AB0A-476F7FF64CDF

P577

Q28386376-EAF8010B-7E67-4875-A5F1-FB7DDB3C54BC

P5875

Q28386376-A6B6039F-BE9E-488F-9BDB-69E1577293AC

P6179

Q28386376-23F7C326-64FF-4ACB-8DEB-FBF266205CE6

P698

Q28386376-4A21EC0C-4D66-44BD-884B-5D6ED12B736D

P921

Q28386376-1D030311-EF52-4FE1-BDBB-0A26C002DCE2

P932

Q28386376-AD488813-6A89-437B-98FF-B4EE9BCE334F

P356

S10439-010-0223-Z

P1433

Annals of Biomedical Engineering

P1476

Characterization of respirator ...... ntire tracheobronchial airways

@en

P2093

Geng Tian

http://www.w3.org/2001/XMLSchema#string

Guoguang Su

http://www.w3.org/2001/XMLSchema#string

Philip Worth Longest

http://www.w3.org/2001/XMLSchema#string

P2860

Particle deposition in a cast of human tracheobronchial airways

Aerosol deposition in the extrathoracic region

CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data

Characterization of Nanoaerosol Size Change During Enhanced Condensational Growth

Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model

Mutual enhancements of CFD modeling and experimental data: a case study of 1-mum particle deposition in a branching airway model.

Effects of mesh style and grid convergence on particle deposition in bifurcating airway models with comparisons to experimental data.

Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.

3D airway reconstruction using visible human data set and human casts with comparison to morphometric data.

Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA

P2888

s10439-010-0223-z

P304

1136-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10439-010-0223-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49678639

http://www.w3.org/2001/XMLSchema#string

P6179

1041546693

http://www.w3.org/2001/XMLSchema#string

P698

21152983

http://www.w3.org/2001/XMLSchema#string

P921

P932

3042232

http://www.w3.org/2001/XMLSchema#string